Journal article icon

Journal article

Plasmodium vivax Malaria Relapse Risk Depends on Transmission Intensity: Evidence From a Longitudinal Study in Northwest Thailand

Abstract:
Background: In northwest Thailand, the provision of radical cure to prevent relapses of Plasmodium vivax malaria has decreased P vivax caseloads and decreased transmission. While malaria control measures were increased, we performed a prospective observational rolling cohort study to describe the changing incidence of P vivax malaria and the associated recurrence rates. Methods: Healthy nonpregnant glucose-6-phosphate dehydrogenase–normal volunteers who had symptomatic P vivax infection in the previous 12–24 months, but who had not received radical cure, were recruited. Supervised primaquine was given daily for 14 days (0.5 mg base/kg/day). Participants were followed 4 and 8 weeks later, then every 2 months until they developed symptomatic or asymptomatic P vivax malaria. Consultation for febrile illnesses was encouraged between follow-up visits. Participants who developed P vivax malaria were replaced with matched volunteers to maintain a continuous cohort of 200 participants. Results: From March 2010 until September 2014, 380 healthy adults and children were enrolled. Ninety-two individuals developed P vivax malaria, 25 within 4 months of enrollment. The annual incidence of P vivax malaria infection decreased from 0.19 in 2010 to 0.09 infections per person-year in 2014. The primaquine failure rate (P vivax malaria within 4 months of treatment) was 75% less than predicted based on earlier assessments that assumed a constant hypnozoite reservoir. Conclusions: Declining P vivax transmission reduces the hypnozoite reservoir in the population and the hypnozoite burden in an individual. This increases the apparent efficacy of radical cure in preelimination settings.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1093/ofid/ofaf667

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-9465-8214
More by this author
Role:
Author
ORCID:
0000-0001-7975-745X
More by this author
Institution:
University of Oxford
Role:
Author


More from this funder
Funder identifier:
https://ror.org/029chgv08


Publisher:
Oxford University Press
Journal:
Open Forum Infectious Diseases More from this journal
Volume:
13
Issue:
1
Pages:
ofaf667
Article number:
ofaf667
Publication date:
2025-10-30
Acceptance date:
2025-10-23
DOI:
EISSN:
2328-8957
ISSN:
2328-8957


Language:
English
Keywords:
Pubs id:
2308607
UUID:
uuid_0bf4b09f-8ec1-4cd7-acf7-6af52fc8785e
Local pid:
pubs:2308607
Source identifiers:
3663462
Deposit date:
2026-01-14
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP